InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Brown Douglas Matthew, Dirigeant. Officer active across 1 companies, notably Neogenomics INC. Cumulatively, 6 disclosures have been logged. Total volume traded: €2.2m. The latest transaction was disclosed on 1 April 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
082,305 shares0
Common Stock
SEC:0001077183-22-000054:0·
035,030 shares0
Common Stock
SEC:0001077183-22-000039:0·
030,572 shares0
Common Stock
SEC:0001077183-21-000271·
030,572 shares0
Common Stock
SEC:0001077183-21-000271:0·
€1m33,333 shares@ €33.08090.10% mcap100.0% of flow
Common Stock
SEC:0001077183-21-000249·
€1m33,333 shares@ €33.08090.10% mcap50.0% of flow
Common Stock
SEC:0001077183-21-000249:0·
6 of 6 declarations
About Brown Douglas Matthew
Douglas Matthew Brown is the Chief Strategy Officer at Neogenomics Inc. He is responsible for developing and implementing the company's strategy. Neogenomics specializes in genetic diagnostic services. Douglas's expertise in strategy is essential for the company's growth and innovation.
